Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FXWEmtGy9ap9UBz6Ccp5sb122jmA.uncropped.jpg&w=3840&q=75)
Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoChange DetectedDifference0.5%
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 151 locations and has been updated from revision v2.9.7 to v2.10.0.SummaryDifference0.6%
- Check8 days agoChange DetectedDifference0.5%
- Check9 days agoChange DetectedDifference0.5%
- Check10 days agoChange DetectedDifference0.5%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.